Noracymethadol (INN) is a synthetic opioid analgesic related to methadone that was never marketed. In a clinical trial of postpartum patients it was reported to produce analgesia comparable to that of morphine but with less nausea dizziness and drowsiness. Other side effects included salivation ataxia and respiratory depression that was reversible by naloxone.
This page contains content from the copyrighted Wikipedia article "Noracymethadol"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
